Tue 20 Oct 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Cabazitaxel | Jevtana | 4.8 Undesirable effects | Mar,2023 |
| Acetylsalicylic Acid | Aspirin® Protect | Drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms | Mar,2023 |
| Zanubrutinib | Brukinsa | 2.3 Dosage Modifications for Drug Interactions | Mar,2023 |
| Methotrexate | Mizotra | 4.6 Fertility, pregnancy and lactation | Mar,2023 |
| Lansoprazole | Takepron | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Mar,2023 |
| Colistimethate Sodium | Colistin | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Mar,2023 |
| Bosutinib | Bosulif | 4.8 Undesirable effects | Mar,2023 |
| Furosemide | Lasix | 4.4 Special Warnings and Special Precautions for Use | Mar,2023 |
| Femara | Letrozole | 4.4 Special Warnings and Special Precautions for Use 4.8 Undesirable effects | Mar,2023 |
| Cephalexin | Keflex | 4.4 Special Warnings and Special Precautions for Use | Mar,2023 |
Last update date: 04/10/2026 at 10:24 AM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.